Autopsy report · NCT03903653

Botulinum Toxin A & Weekly Serial Casting in ABI Inpatients With Lower Extremity Spasticity

“unable to enroll patients due to closure of our inpatient units secondary to COVID-19.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Hamilton Health Sciences Corporation

Sponsor type

University, hospital or other

Conditions

Spastic Foot

Interventions

Botulinum toxin type A; Serial Casting

Participants

0

Trials that died the same way

• Investigating the Effects of Mikei® Red Reishi Essence EX on the Immune System of Prostate Cancer Patients and Patients With Non-cancerous Conditions of the Prostate
  “Covid 19 Pandemic - Unable to enroll patients” (80% match in meaning)
• Effects of rTMS on Human Brain Activity
  “Never started enrollment due to COVID-19 closures” (74% match in meaning)
• Effects of High Caffeine Content Coffee on Blood Pressure in Young Adults
  “not possible to enroll during COVID pandemic” (70% match in meaning)
• A Biomarker Evaluation Trial of UAB30 in Renal Transplant Recipients at High Risk for Non-melanoma Skin Cancer
  “COVID-19 pandemic, unable to enroll participants” (70% match in meaning)
• Acthar as Rescue Therapy for Transplant Glomerulopathy in Kidney Transplant Recipients
  “Unable to enroll patients, no longer at institution.” (69% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.